200 related articles for article (PubMed ID: 32936729)
1. Hippocampal blood-brain barrier permeability is related to the APOE4 mutation status of elderly individuals without dementia.
Moon WJ; Lim C; Ha IH; Kim Y; Moon Y; Kim HJ; Han SH
J Cereb Blood Flow Metab; 2021 Jun; 41(6):1351-1361. PubMed ID: 32936729
[TBL] [Abstract][Full Text] [Related]
2. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
Montagne A; Nation DA; Sagare AP; Barisano G; Sweeney MD; Chakhoyan A; Pachicano M; Joe E; Nelson AR; D'Orazio LM; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Reiman EM; Caselli RJ; Chui HC; Tcw J; Chen Y; Pa J; Conti PS; Law M; Toga AW; Zlokovic BV
Nature; 2020 May; 581(7806):71-76. PubMed ID: 32376954
[TBL] [Abstract][Full Text] [Related]
3. Sex-Related Differences in Regional Blood-Brain Barrier Integrity in Non-Demented Elderly Subjects.
Moon Y; Lim C; Kim Y; Moon WJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799794
[TBL] [Abstract][Full Text] [Related]
4. Effects of ApoE4 and maternal history of dementia on hippocampal atrophy.
Andrawis JP; Hwang KS; Green AE; Kotlerman J; Elashoff D; Morra JH; Cummings JL; Toga AW; Thompson PM; Apostolova LG
Neurobiol Aging; 2012 May; 33(5):856-66. PubMed ID: 20833446
[TBL] [Abstract][Full Text] [Related]
5. Regional Differences in Blood-Brain Barrier Permeability in Cognitively Normal Elderly Subjects: A Dynamic Contrast-Enhanced MRI-Based Study.
Ha IH; Lim C; Kim Y; Moon Y; Han SH; Moon WJ
Korean J Radiol; 2021 Jul; 22(7):1152-1162. PubMed ID: 33739632
[TBL] [Abstract][Full Text] [Related]
6. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
[TBL] [Abstract][Full Text] [Related]
7. Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume.
Striepens N; Scheef L; Wind A; Meiberth D; Popp J; Spottke A; Kölsch H; Wagner M; Jessen F
Psychol Med; 2011 Sep; 41(9):1997-2006. PubMed ID: 21284913
[TBL] [Abstract][Full Text] [Related]
8. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.
Halliday MR; Rege SV; Ma Q; Zhao Z; Miller CA; Winkler EA; Zlokovic BV
J Cereb Blood Flow Metab; 2016 Jan; 36(1):216-27. PubMed ID: 25757756
[TBL] [Abstract][Full Text] [Related]
9. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
Low A; Ng KP; Chander RJ; Wong B; Kandiah N
J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
[TBL] [Abstract][Full Text] [Related]
10. Damage of the temporal lobe and APOE status determine neural compensation in mild cognitive impairment.
Prieto Del Val L; Cantero JL; Baena D; Atienza M
Cortex; 2018 Apr; 101():136-153. PubMed ID: 29475078
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.
Kim YJ; Cho H; Kim YJ; Ki CS; Chung SJ; Ye BS; Kim HJ; Kim JH; Kim ST; Lee KH; Jeon S; Lee JM; Chin J; Kim JH; Na DL; Seong JK; Seo SW
J Alzheimers Dis; 2015; 44(4):1075-85. PubMed ID: 25391384
[TBL] [Abstract][Full Text] [Related]
12. Increase of blood-brain barrier leakage is related to cognitive decline in vascular mild cognitive impairment.
Li M; Li Y; Zuo L; Hu W; Jiang T
BMC Neurol; 2021 Apr; 21(1):159. PubMed ID: 33858381
[TBL] [Abstract][Full Text] [Related]
13. Large intracranial volume accelerates conversion to dementia in males and APOE4 non-carriers with mild cognitive impairment.
An H; Son SJ; Cho S; Cho EY; Choi B; Kim SY;
Int Psychogeriatr; 2016 May; 28(5):769-78. PubMed ID: 26674540
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study.
Sakurai R; Montero-Odasso M
J Gerontol A Biol Sci Med Sci; 2017 Nov; 72(12):1676-1682. PubMed ID: 28482102
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
Chung JK; Plitman E; Nakajima S; Caravaggio F; Iwata Y; Gerretsen P; Kim J; Takeuchi H; Shinagawa S; Patel R; Chakravarty MM; Graff-Guerrero A;
J Alzheimers Dis; 2017; 58(3):747-762. PubMed ID: 28505977
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
17. Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls.
Wang H; Golob EJ; Su MY
J Magn Reson Imaging; 2006 Sep; 24(3):695-700. PubMed ID: 16878309
[TBL] [Abstract][Full Text] [Related]
18. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
[TBL] [Abstract][Full Text] [Related]
19. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
